8-K - Definium Therapeutics, Inc. (0001813814) (Filer)
Published . Updated .
Key takeaways
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Definium Therapeutics filed an 8-K with the SEC on Nov 9 (a notice of a material company event).
Directly affected
- DFTX Definium Therapeutics-10.8% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Definium Therapeutics belongs to, so it often moves with news about it.
- LLY Eli Lilly and+14.3% 30d
Eli Lilly and is a large health company like Definium Therapeutics; big names in a sector often move together.
- JNJ Johnson & Johnson+3.3% 30d
Johnson & Johnson is a large health company like Definium Therapeutics; big names in a sector often move together.
- ABBV AbbVie+9.3% 30d
AbbVie is a large health company like Definium Therapeutics; big names in a sector often move together.
- MRK Merck+3.4% 30d
Merck is a large health company like Definium Therapeutics; big names in a sector often move together.
- AMGN Amgen+10.1% 30d
Amgen is a large health company like Definium Therapeutics; big names in a sector often move together.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| DFTX | -5.57% | -14.23% | base | after close | after close | after close | after close |
| XLV | -2.33% | -1.82% | base | after close | after close | after close | after close |
| LLY | -0.21% | -3.19% | base | after close | after close | after close | after close |
| JNJ | -5.66% | -3.43% | base | after close | after close | after close | after close |
| ABBV | -2.53% | -1.82% | base | after close | after close | after close | after close |
| MRK | -2.73% | -1.23% | base | after close | after close | after close | after close |
| AMGN | -0.87% | -1.01% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-09 AccNo: 0001193125-26-453595 Size: 561 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Definium Therapeutics (DFTX) since “8-K - Definium Therapeutics, Inc. (0001813814) (Filer),” compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| AbbVie (ABBV) | three days earlier | -1.82% | final price |
| AbbVie (ABBV) | five days earlier | -2.53% | final price |
| Amgen (AMGN) | three days earlier | -1.01% | final price |
| Amgen (AMGN) | five days earlier | -0.87% | final price |
| Definium Therapeutics (DFTX) | three days earlier | -14.23% | final price |
| Definium Therapeutics (DFTX) | five days earlier | -5.57% | final price |
| Johnson & Johnson (JNJ) | three days earlier | -3.43% | final price |
| Johnson & Johnson (JNJ) | five days earlier | -5.66% | final price |
| Eli Lilly (LLY) | three days earlier | -3.19% | final price |
| Eli Lilly (LLY) | five days earlier | -0.21% | final price |
| Merck (MRK) | three days earlier | -1.23% | final price |
| Merck (MRK) | five days earlier | -2.73% | final price |
| Select Sector Spdr Tr (XLV) | three days earlier | -1.82% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | -2.33% | final price |
Congressional trades in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 66 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 40 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 45 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 62 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 56 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 66 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 46 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 82 days before publication. Filed 9 Sep 2026. View the filing.
- Sen. Sheldon Whitehouse sold Amgen (AMGN) (held by a spouse), worth $15,001 - $50,000 on 15 Oct 2026. That is 25 days before publication. Filed 2 Nov 2026. View the filing.
- Rep. David J. Taylor bought Amgen (AMGN), worth $1,001 - $15,000 on 22 Sep 2026. That is 48 days before publication. Filed 1 Oct 2026. View the filing.
- Rep. David J. Taylor sold Amgen (AMGN), worth $1,001 - $15,000 on 26 Aug 2026. That is 75 days before publication. Filed 5 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Definium Therapeutics (DFTX)
Companies mentioned with this story
- DFTX Definium Therapeutics
In “8-K - Definium Therapeutics, Inc. (0001813814) (Filer),” Definium Therapeutics (DFTX) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> DFTX
- XLV Select Sector Spdr Tr
Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence in the 9 Nov 2026 story “8-K - Definium Therapeutics, Inc. (0001813814) (Filer).” Reason on file: Health Care Select Sector SPDR holds the health sector that Definium Therapeutics belongs to, so it often moves with news about it
- LLY Eli Lilly
For “8-K - Definium Therapeutics, Inc. (0001813814) (Filer),” Eli Lilly (LLY) is linked, with no stored direction, medium confidence. Reason on file: Eli Lilly and is a large health company like Definium Therapeutics; big names in a sector often move together
- JNJ Johnson & Johnson
For “8-K - Definium Therapeutics, Inc. (0001813814) (Filer),” Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence. Reason on file: Johnson & Johnson is a large health company like Definium Therapeutics; big names in a sector often move together
- ABBV AbbVie
In “8-K - Definium Therapeutics, Inc. (0001813814) (Filer),” AbbVie (ABBV) is linked, with no stored direction, medium confidence. Reason on file: AbbVie is a large health company like Definium Therapeutics; big names in a sector often move together
- MRK Merck
Merck (MRK) is linked, with no stored direction, medium confidence in the 9 Nov 2026 story “8-K - Definium Therapeutics, Inc. (0001813814) (Filer).” Reason on file: Merck is a large health company like Definium Therapeutics; big names in a sector often move together
- AMGN Amgen
For “8-K - Definium Therapeutics, Inc. (0001813814) (Filer),” Amgen (AMGN) is linked, with no stored direction, medium confidence. Reason on file: Amgen is a large health company like Definium Therapeutics; big names in a sector often move together
How “8-K - Definium Therapeutics, Inc. (0001813814) (Filer)” reaches Definium Therapeutics (DFTX)
“8-K - Definium Therapeutics, Inc. (0001813814) (Filer)” (9 Nov 2026) reaches Definium Therapeutics (DFTX) through this story.
What ties Definium Therapeutics (DFTX) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> DFTX
Also listed, Select Sector Spdr Tr (XLV): Health Care Select Sector SPDR holds the health sector that Definium Therapeutics belongs to, so it often moves with news about it
Dates in the story, and the Definium Therapeutics (DFTX) price range
DFTX traded between 31.65 and 39.14 across 20 sessions. The latest close on file is 32.72. LLY traded between 1158.27 and 1452.66 across 20 sessions. The latest close on file is 1354.96.
How strong the case is around Definium Therapeutics (DFTX)
46 out of 100
“8-K - Definium Therapeutics, Inc. (0001813814) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.